SI1401445T1 - Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila - Google Patents

Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila

Info

Publication number: SI1401445T1
Authority: SI; Slovenia
Prior art keywords: production; drug; anticholinergic; crystalline; crystalline anticholinergic
Prior art date: 2001-06-22

Application number

SI200230431T

Other languages

English (en)

Inventor

Peter Sieger

Ulrike Werthmann

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-22

Filing date

2002-06-08

Publication date

2007-02-28

2002-06-08 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2007-02-28 Publication of SI1401445T1 publication Critical patent/SI1401445T1/sl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pulmonology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

SI200230431T 2001-06-22 2002-06-08 Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila SI1401445T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10129710		2001-06-22
DE10215436		2002-04-08
PCT/EP2002/006291 WO2003000265A1 (de)	2001-06-22	2002-06-08	Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (1)

Publication Number	Publication Date
SI1401445T1 true SI1401445T1 (sl)	2007-02-28

Family

ID=26009556

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200230431T SI1401445T1 (sl)	2001-06-22	2002-06-08	Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila

Country Status (38)

Country	Link
EP (1)	EP1401445B1 (sl)
JP (1)	JP2005504015A (sl)
KR (2)	KR101011353B1 (sl)
CN (1)	CN100586948C (sl)
AR (1)	AR037491A1 (sl)
AT (1)	ATE337006T1 (sl)
AU (1)	AU2002345016B2 (sl)
BG (1)	BG66303B1 (sl)
BR (1)	BR0210537A (sl)
CA (1)	CA2450961C (sl)
CO (1)	CO5550423A2 (sl)
CY (1)	CY1105223T1 (sl)
CZ (1)	CZ302786B6 (sl)
DE (1)	DE50207943D1 (sl)
DK (1)	DK1401445T3 (sl)
EA (1)	EA005813B1 (sl)
EE (1)	EE05316B1 (sl)
EG (1)	EG24851A (sl)
ES (1)	ES2271280T3 (sl)
HK (1)	HK1068540A1 (sl)
HR (1)	HRP20031066B1 (sl)
HU (1)	HUP0400333A3 (sl)
IL (2)	IL159238A0 (sl)
ME (1)	ME00412B (sl)
MX (1)	MXPA03011718A (sl)
MY (1)	MY122779A (sl)
NO (1)	NO334301B1 (sl)
NZ (1)	NZ530690A (sl)
PE (2)	PE20081305A1 (sl)
PL (1)	PL208137B1 (sl)
PT (1)	PT1401445E (sl)
RS (1)	RS50441B (sl)
SA (1)	SA02230255B1 (sl)
SI (1)	SI1401445T1 (sl)
SK (1)	SK287262B6 (sl)
TW (2)	TW200617007A (sl)
UY (1)	UY27342A1 (sl)
WO (1)	WO2003000265A1 (sl)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US20050038004A1 (en) *	2003-07-31	2005-02-17	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
SI1682542T1 (sl) *	2003-11-03	2010-04-30	Boehringer Ingelheim Int	Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
ATE539754T1 (de)	2004-04-22	2012-01-15	Boehringer Ingelheim Int	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2322148T3 (es)	2004-08-11	2009-06-17	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
JP5053997B2 (ja)	2005-04-28	2012-10-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	炎症性疾患の治療用の新規化合物
AU2006243238B2 (en) *	2005-05-02	2012-05-24	Boehringer Ingelheim International Gmbh	Novel crystalline forms of tiotropium bromide
RU2007144531A (ru) *	2005-05-02	2009-06-10	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	Новые кристаллические формы тиотропийбромида
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
ES2530991T3 (es)	2005-08-15	2015-03-09	Boehringer Ingelheim Int	Procedimiento para la obtención de betamiméticos
TWI396541B (zh)	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
US9108962B2 (en)	2005-12-19	2015-08-18	Sicor, Inc.	Forms of tiotropium bromide and processes for preparation thereof
PL2123650T3 (pl) *	2005-12-19	2012-09-28	Sicor Inc	Nowa postać bromku tiotropium i sposób jej wytwarzania
CN100999521B (zh) *	2006-01-13	2010-12-08	江苏正大天晴药业股份有限公司	结晶性抗胆碱药噻托溴铵
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP1874781B9 (de)	2006-04-19	2010-09-08	Boehringer Ingelheim International GmbH	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE505193T1 (de)	2006-08-07	2011-04-15	Boehringer Ingelheim Int	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080610A1 (es)	2006-08-22	2008-07-15	Boehringer Ingelheim Int	Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
GB0716026D0 (en)	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
CA2705414C (en)	2007-10-19	2016-05-24	Boehringer Ingelheim International Gmbh	Substituted piperidino-dihydrothienopyrimidines
EP2093219A1 (de)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
EP2379525B1 (en)	2008-12-19	2015-07-29	Boehringer Ingelheim International GmbH	Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
EP2403851B1 (en)	2009-03-06	2015-06-17	Mahmut Bilgic	New crystalline forms of tiotropium bromide
ES2524829T3 (es)	2009-12-17	2014-12-12	Boehringer Ingelheim International Gmbh	Nuevos antagonistas del receptor CCR2 y usos de los mismos
JP5658272B2 (ja)	2009-12-17	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
EP2528915B1 (en)	2010-01-29	2015-10-28	Boehringer Ingelheim International GmbH	Substituted naphthyridines and their use as syk kinase inhibitors
WO2011141477A1 (en)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (ja)	2010-05-12	2013-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
EP2571870B1 (en)	2010-05-17	2015-01-21	Boehringer Ingelheim International GmbH	Ccr2 antagonists and uses thereof
US9018212B2 (en)	2010-05-25	2015-04-28	Boehringer Ingelheim International Gmbh	Pyridazine carboxamides as CCR2 receptor antagonists
US8962656B2 (en)	2010-06-01	2015-02-24	Boehringer Ingelheim International Gmbh	CCR2 antagonists
TR201007108A2 (tr) *	2010-08-25	2012-03-21	B�Lg�� Mahmut	Yeni tiotropyum bromür kristali ve üretim yöntemi.@
EP2668177B1 (en)	2011-01-28	2014-10-22	Boehringer Ingelheim International GmbH	Substituted pyridinyl-pyrimidines and their use as medicaments
TR201101897A2 (tr)	2011-02-28	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal madde
TR201111589A2 (tr) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür susuz kristal formu.
TR201102068A2 (tr)	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
JP5786257B2 (ja)	2011-06-16	2015-09-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規の選択的ｃｃｒ２拮抗薬
EP2731941B1 (en)	2011-07-15	2019-05-08	Boehringer Ingelheim International GmbH	Novel and selective ccr2 antagonists
AU2012288969B2 (en)	2011-07-26	2017-02-23	Boehringer Ingelheim International Gmbh	Substituted quinolines and their use as medicaments
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
DK2782914T3 (en)	2011-11-25	2018-11-26	Adverio Pharma Gmbh	PROCEDURE FOR PREPARING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPYRIDINES
CZ304368B6 (cs)	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
PT106142B (pt) *	2012-02-10	2014-07-18	Hovione Farmaci Ncia S A	Processo para a preparação de brometo de tiotrópio
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
WO2014042605A1 (en) *	2012-09-11	2014-03-20	Mahmut Bilgic	New tiotropium bromide crystalline form
CN104797579A (zh)	2012-11-05	2015-07-22	赞蒂瓦有限合伙公司	噻托溴铵溶剂化物的稳定化
CN104341412A (zh) *	2013-07-29	2015-02-11	天津金耀集团有限公司	一种无水噻托溴铵结晶的制备方法
WO2015140051A1 (en)	2014-03-19	2015-09-24	Boehringer Ingelheim International Gmbh	Heteroaryl sik inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
HUE051693T2 (hu)	2014-10-21	2021-03-29	Ariad Pharma Inc	5-Klór-N4-[2-(dimetilfoszforil)-fenil]-N2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)-piperidin-1-il] -pirimidin-2,4-diamin kristályos formái
WO2017138896A1 (en) *	2016-02-11	2017-08-17	Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti	Crystalline form of tiotropium bromide anhydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
MEP40008A (en) *	2000-10-12	2011-02-10	Boehringer Ingelheim Pharma	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
DE10064816A1 (de) *	2000-12-22	2002-06-27	Boehringer Ingelheim Pharma	Verfahren zur Herstellung eines Anticholinergikums

2002
- 2002-06-08 KR KR1020097004823A patent/KR101011353B1/ko active IP Right Grant
- 2002-06-08 IL IL15923802A patent/IL159238A0/xx unknown
- 2002-06-08 BR BR0210537-3A patent/BR0210537A/pt active Pending
- 2002-06-08 HU HU0400333A patent/HUP0400333A3/hu unknown
- 2002-06-08 JP JP2003506910A patent/JP2005504015A/ja active Pending
- 2002-06-08 PL PL364489A patent/PL208137B1/pl unknown
- 2002-06-08 RS YUP-997/03A patent/RS50441B/sr unknown
- 2002-06-08 AT AT02743165T patent/ATE337006T1/de active
- 2002-06-08 EA EA200301293A patent/EA005813B1/ru not_active IP Right Cessation
- 2002-06-08 ME MEP-2008-620A patent/ME00412B/me unknown
- 2002-06-08 NZ NZ530690A patent/NZ530690A/en not_active IP Right Cessation
- 2002-06-08 CN CN02812303A patent/CN100586948C/zh not_active Expired - Lifetime
- 2002-06-08 CZ CZ20040120A patent/CZ302786B6/cs not_active IP Right Cessation
- 2002-06-08 ES ES02743165T patent/ES2271280T3/es not_active Expired - Lifetime
- 2002-06-08 CA CA2450961A patent/CA2450961C/en not_active Expired - Fee Related
- 2002-06-08 WO PCT/EP2002/006291 patent/WO2003000265A1/de active Application Filing
- 2002-06-08 MX MXPA03011718A patent/MXPA03011718A/es active IP Right Grant
- 2002-06-08 KR KR1020037016769A patent/KR100971616B1/ko active IP Right Grant
- 2002-06-08 AU AU2002345016A patent/AU2002345016B2/en not_active Expired
- 2002-06-08 SK SK52-2004A patent/SK287262B6/sk unknown
- 2002-06-08 EE EEP200400029A patent/EE05316B1/xx unknown
- 2002-06-08 PT PT02743165T patent/PT1401445E/pt unknown
- 2002-06-08 EP EP02743165A patent/EP1401445B1/de not_active Expired - Lifetime
- 2002-06-08 DK DK02743165T patent/DK1401445T3/da active
- 2002-06-08 DE DE50207943T patent/DE50207943D1/de not_active Expired - Lifetime
- 2002-06-08 SI SI200230431T patent/SI1401445T1/sl unknown
- 2002-06-19 TW TW095100968A patent/TW200617007A/zh unknown
- 2002-06-19 TW TW091113373A patent/TWI261589B/zh not_active IP Right Cessation
- 2002-06-19 EG EG2002060698A patent/EG24851A/xx active
- 2002-06-20 UY UY27342A patent/UY27342A1/es not_active Application Discontinuation
- 2002-06-20 MY MYPI20022316A patent/MY122779A/en unknown
- 2002-06-21 PE PE2007000660A patent/PE20081305A1/es not_active Application Discontinuation
- 2002-06-21 AR ARP020102337A patent/AR037491A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2002-06-21 PE PE2002000538A patent/PE20030130A1/es active IP Right Grant
- 2002-08-19 SA SA2230255A patent/SA02230255B1/ar unknown
2003
- 2003-12-08 IL IL159238A patent/IL159238A/en active IP Right Grant
- 2003-12-12 BG BG108440A patent/BG66303B1/bg active Active
- 2003-12-19 HR HR20031066A patent/HRP20031066B1/xx not_active IP Right Cessation
- 2003-12-19 NO NO20035696A patent/NO334301B1/no not_active IP Right Cessation
2004
- 2004-01-20 CO CO04003764A patent/CO5550423A2/es not_active Application Discontinuation
2005
- 2005-01-29 HK HK05100780.9A patent/HK1068540A1/xx not_active IP Right Cessation
2006
- 2006-09-20 CY CY20061101339T patent/CY1105223T1/el unknown

Also Published As

Publication number	Publication date
HRP20031066A2 (en)	2004-04-30
ME00412B (me)	2011-10-10
WO2003000265A1 (de)	2003-01-03
KR100971616B1 (ko)	2010-07-22
IL159238A (en)	2010-04-15
CA2450961C (en)	2010-03-30
CY1105223T1 (el)	2010-03-03
SK522004A3 (en)	2004-06-08
EA200301293A1 (ru)	2004-08-26
NO334301B1 (no)	2014-02-03
CZ302786B6 (cs)	2011-11-09
CZ2004120A3 (cs)	2004-05-12
HUP0400333A2 (hu)	2004-12-28
EG24851A (en)	2010-10-27
YU99703A (sh)	2006-05-25
SK287262B6 (sk)	2010-04-07
TW200617007A (en)	2006-06-01
NO20035696D0 (no)	2003-12-19
BG108440A (en)	2004-08-31
CA2450961A1 (en)	2003-01-03
PE20081305A1 (es)	2008-10-01
HRP20031066B1 (en)	2011-10-31
AR037491A1 (es)	2004-11-17
EE05316B1 (et)	2010-08-16
HK1068540A1 (en)	2005-04-29
RS50441B (sr)	2010-03-02
EA005813B1 (ru)	2005-06-30
EP1401445B1 (de)	2006-08-23
EE200400029A (et)	2004-04-15
JP2005504015A (ja)	2005-02-10
ATE337006T1 (de)	2006-09-15
BR0210537A (pt)	2004-06-22
PE20030130A1 (es)	2003-04-02
MEP62008A (en)	2011-05-10
IL159238A0 (en)	2004-06-01
MXPA03011718A (es)	2004-12-06
CN1520294A (zh)	2004-08-11
CN100586948C (zh)	2010-02-03
NZ530690A (en)	2005-05-27
PT1401445E (pt)	2006-10-31
DE50207943D1 (de)	2006-10-05
PL364489A1 (en)	2004-12-13
PL208137B1 (pl)	2011-03-31
EP1401445A1 (de)	2004-03-31
KR20040018285A (ko)	2004-03-02
SA02230255B1 (ar)	2006-10-31
DK1401445T3 (da)	2006-11-27
HUP0400333A3 (en)	2012-10-29
CO5550423A2 (es)	2005-08-31
KR101011353B1 (ko)	2011-01-28
AU2002345016B2 (en)	2008-04-17
BG66303B1 (bg)	2013-03-29
TWI261589B (en)	2006-09-11
UY27342A1 (es)	2003-02-28
MY122779A (en)	2006-05-31
ES2271280T3 (es)	2007-04-16
KR20090031638A (ko)	2009-03-26

Publication	Publication Date	Title
HK1068540A1 (en)	2005-04-29	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002345016A1 (en)	2003-06-19	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU1499602A (en)	2002-04-22	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU2002214996A1 (en)	2002-06-27	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
IL155334A0 (en)	2003-11-23	Novel anticholinergic agents that can be used as medicaments and method for the production thereof
AU2002213975A1 (en)	2002-07-04	Novel anticholinergic agents that can be used as medicaments and method for the production thereof
HK1077818A1 (en)	2006-02-24	Anticholinergic agents, method for producing the same and use thereof as medicaments
AU6231801A (en)	2001-12-17	Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0300327A3 (en)	2004-10-28	Percyquinnin, a process for its production and its use as a pharmaceutical
AU2002213977A1 (en)	2002-04-29	Novel anticholinergics, method for the production thereof and use thereof as medicaments
IL191790A0 (en)	2008-12-29	Xanthine derivatives, production and use thereof as a medicament
AU2003206760A1 (en)	2003-09-18	Anticholinergic agents, method for producing the same and use thereof as medicaments
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
TWI318211B (en)	2009-12-11	Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
AU6222901A (en)	2001-11-12	Cyclipostins, a method for their production and the use of the same
ZA200308591B (en)	2004-05-12	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug.
HK1061655A1 (en)	2004-09-30	Caloporoside derivatives, methods for the production thereof and their use
HUP0302989A3 (en)	2007-06-28	Benzamidine derivatives and process for production thereof
HUP0203593A3 (en)	2003-12-29	Amycomycin, a process for its production and its use as a pharmaceutical
SI1294682T1 (sl)	2004-10-31	Acilfenilsečninski derivati, postopki za njihovo pripravo in njihova uporaba kot zdravila
SI1456212T1 (sl)	2007-04-30	Derivati 6-aminomorfinana, postopek za njihovo izdelavo in njihova uporaba
SI1372670T1 (sl)	2005-10-31	Kaloporozidni derivati, prostopek za njihovo pripravo in njihova uporaba